Positron emission tomography: theory and its application to the study of lung disease.
暂无分享,去创建一个
[1] J. Frost. Receptor localization and quantification with PET. , 1988, Radiology.
[2] M. Mintun,et al. Pulmonary vascular permeability during the adult respiratory distress syndrome: a positron emission tomographic study. , 1988, The American review of respiratory disease.
[3] S. Matsui,et al. Annealing effects for implanted Y‐Ba‐Cu‐O superconductors , 1988 .
[4] Acnp Snm Task Force on Clinical Pet. Positron Emission Tomography: Clinical Status in the United States in 1987 , 1988 .
[5] W. R. Kennedy,et al. Cyclotrons and Radiopharmaceuticals in Positron Emission Tomography , 1988 .
[6] D. Schuster,et al. Quantifying the effects of mixed venous PO2 on regional pulmonary perfusion with positron emission tomography during lobar hypoxic ventilation in dogs , 1988 .
[7] T Jones,et al. Glucose utilization in vivo by human pulmonary neoplasms , 1987, Cancer.
[8] H. M. Thomas,et al. Lipoxygenase and cyclooxygenase blockade by BW 755C enhances pulmonary hypoxic vasoconstriction. , 1987, Journal of applied physiology.
[9] K. B. Larson,et al. Strategies for in vivo Measurement of Receptor Binding Using Positron Emission Tomography , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[10] M. Mintun,et al. Regional lung water and hematocrit determined by positron emission tomography. , 1985, Journal of applied physiology.
[11] J. Mazziotta,et al. Positron emission tomography: human brain function and biochemistry. , 1985, Science.
[12] M. Heymann,et al. Leukotriene Inhibition Prevents and Reverses Hypoxic Pulmonary Vasoconstriction in Newborn Lambs , 1985, Pediatric Research.
[13] M E Raichle,et al. Positron emission tomography and its application to the study of cerebrovascular disease in man. , 1985, Stroke.
[14] H. Sugerman,et al. Gamma scintigraphic analysis of albumin flux in patients with acute respiratory distress syndrome. , 1984, Surgery.
[15] N. Voelkel,et al. Leukotriene synthesis and receptor blockers block hypoxic pulmonary vasoconstriction. , 1984, Journal of applied physiology: respiratory, environmental and exercise physiology.
[16] B. Sobel,et al. Cardiac positron tomography. , 1983, Chest.
[17] J. Baron,et al. 11C-Labeled ketanserin: A selective serotonin S2 antagonist , 1983 .
[18] J. Benumof,et al. PAO2 and PVO2 interaction on hypoxic pulmonary vasoconstriction. , 1982, Journal of applied physiology: respiratory, environmental and exercise physiology.
[19] M. Ter-pogossian. Special characteristics and potential for dynamic function studies with PET. , 1982, Seminars in nuclear medicine.
[20] J C Mazziotta,et al. Quantitation in Positron Emission Computed Tomography: 5. Physical–Anatomical Effects , 1981, Journal of computer assisted tomography.
[21] G. Beller,et al. Scintigraphic detection of pulmonary emboli by serial positron imaging of inhaled 15O-labeled carbon dioxide. , 1978, The New England journal of medicine.
[22] M J Welch,et al. Measurement of regional substrate utilization rates by emission tomography. , 1978, Science.
[23] J. West,et al. Ventilation-perfusion inequality in chronic obstructive pulmonary disease. , 1977, The Journal of clinical investigation.
[24] P. Buckingham,et al. Distribution of extravascular fluid volumes in isolated perfused lungs measured with H215O. , 1976, The Journal of clinical investigation.
[25] Preparation of short half-lived radioactive gases for medical studies. , 1968, Radiation research.
[26] W. Milnor,et al. The Pulmonary Blood Volume in Rheumatic Heart Disease and Its Alteration by Isoproterenol , 1963, Circulation.